Phibro Animal Health (PAHC) Change in Cash (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Change in Cash came in at -$557000.0 in Q1 2026, up 91.71% year-on-year from -$290541.0 in Q1 2025, and up 96.78% quarter-over-quarter from -$17.3 million in Q4 2025.
Phibro Animal Health (PAHC) Change in Cash (2013 - 2026) Analysis & Trends
Phibro Animal Health's Change in Cash history runs 14 years deep, the most recent figure standing at -$557000.0 for Q1 2026.
- On a quarterly basis, Change in Cash rose 91.71% year-over-year to -$557000.0 in Q1 2026; TTM through Mar 2026 was -$5.4 million, a 153.56% decrease from a year earlier, with the FY2025 full-year figure at -$2.6 million, down 108.78% from the prior year.
- Change in Cash rose to -$557000.0 in Q1 2026 per PAHC's latest filing, from -$17.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $20.4 million in Q2 2024 and bottomed at -$31.2 million in Q1 2023.
- The 5-year median for Change in Cash is $2.0 million (2022), against an average of -$497411.8.
- Biggest YoY gain for Change in Cash was 404.28% in 2024; the steepest drop was 1102.99% in 2024.
- Year by year, Change in Cash stood at -$7.9 million in 2022, then decreased by 29.59% to -$10.2 million in 2023, then jumped by 249.63% to $15.2 million in 2024, then tumbled by 213.43% to -$17.3 million in 2025, then surged by 96.78% to -$557000.0 in 2026.
- Per Business Quant, the three latest PAHC Change in Cash figures stand at -$557000.0 (Q1 2026), -$17.3 million (Q4 2025), and $4.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | -557,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -557,000.00 |
| Dec 31, 2025 | -17.28 Mn |
| Sep 30, 2025 | 4.73 Mn |
| Jun 30, 2025 | 7.69 Mn |
| Mar 31, 2025 | -6.72 Mn |
| Dec 31, 2024 | 15.24 Mn |
| Sep 30, 2024 | -18.78 Mn |
| Jun 30, 2024 | 20.39 Mn |
| Mar 31, 2024 | 17.26 Mn |
| Dec 31, 2023 | -10.18 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 4.04 Mn |
| Mar 31, 2023 | -31.18 Mn |
| Dec 31, 2022 | -7.86 Mn |
| Sep 30, 2022 | 2.03 Mn |
| Jun 30, 2022 | 3.50 Mn |
| Mar 31, 2022 | 7.36 Mn |
| Dec 31, 2021 | 22.21 Mn |
| Sep 30, 2021 | -9.04 Mn |
| Jun 30, 2021 | 1.11 Mn |